63 reports

  • HIGH GROWTH POTENTIAL OF DERMATOLOGY CAMERAS
  • Global dermatology cameras market 2016-2021 ($ millions)

However, it causes more than ##% of skin cancer deaths.

  • Camera
  • Dermatology
  • Market Size
  • Olympus Corporation
  • Stryker Corporation
  • DERMATOLOGY PRODUCTS AND R&D PIPELINE - MERCK
  • DERMATOLOGY M&AS - MERCK

TYPES AND SYMPTOMS OF SKIN CANCER SKIN CANCER ACCOUNTS FOR OVER ##% OF ALL CANCERS.

  • Dermatology
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • Global RF Ablation Devices Market at Dermatology and Cosmetology Clinics : 2015 -
  • 5.2.2 Market Size and Forecast 2017 - 2021 (US$ Million)

Moles, tags, warts may be treated at hospitals under suspicion of skin cancer.

  • Dermatology
  • Covidien plc
  • Lumenis Ltd.
  • Medtronic, Inc.
  • Solta Medical, Inc.
  • Dermatology Therapeutics Market, Global, Pipeline Programs Targeting TLR8, 2017
  • Dermatology Therapeutics Market, Global, Pipeline Programs Targeting Galectin-3, 2017

Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD## and MicroRNA-##.

  • Dermatology
  • World
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.

Galderma is involved in research, developing, and manufacturing of dermatological products, and aesthetic and corrective medical solutions for acne, onychomycosis, skin cancer, rosacea, psoriasis and atopic dermatitis, pigmentary disorders, and skin senescence.

  • Dermatological Treatment
  • Dermatology
  • Therapy
  • Allergan plc
  • Galderma S.A.
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS FOR
  • DERMATOLOGY, GLOBAL, TABLE OF ALL CLINICAL STAGE PIPELINE PRODUCTS, 2016 PART 7

However, Metolate tends to target rapidly replicating cells, such as psoriatic skin cells or cancer cells.

  • Dermatology
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.

Similarly, each year Cancer Council Australia and the Australasian College of Dermatologists come together for National Skin Cancer Action Week.

  • Dermatology
  • Microscope
  • United States
  • World
  • Forecast
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS

However, Metolate tends to target rapidly replicating cells, such as psoriatic skin cells or cancer cells.

  • Dermatology
  • World
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.
  • Products and services segmentation (2016)
  • OTHER COMPANIES

Skin cancer is currently the most common form of cancer and the American Cancer Society estimates that US physicians diagnose more than ##. ## million cases of skin cancer each year.

  • Dermatology
  • Health Care Provider
  • Healthcare
  • United States
  • Forecast

Dermatology diagnostic devices include skin cancer diagnosis and other diagnostic applications.

  • Dermatology
  • Health Services
  • World
  • Forecast
  • ASIAN DERMATOLOGY DIAGNOSTIC DEVICES MARKET OVERVIEW,
  • EUROPE DERMATOLOGY DIAGNOSTIC DEVICES MARKET OVERVIEW,

Among these disorders, melanoma is a type of skin cancer that predominantly develops on skin.

  • Dermatology
  • World
  • Bruker Corporation
  • Carl Zeiss AG
  • FEI Company

It offers drugs for the treatment of respiratory, cancer, cardiovascular, HIV and infectious diseases, respiratory, immuno-inflammation and rare diseases.

  • Dermatology
  • United States
  • Allergan plc
  • Anterios, Inc.
  • Brickell Biotech, Inc.
  • Global dermatology diagnostic devices market 2015-2019 by application
  • Segmentation of mobile apps in dermatology by platforms
  • Dermatology
  • Microscope
  • Market Size
  • MELA Sciences, Inc.
  • Welch Allyn Inc.

Melanoma is a life-threatening skin cancer, which often results due to these skin disorders.

  • Dermatology
  • Health Services

Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others.............. ## Table ##: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown

  • Dermatology
  • Hepatitis
  • Pathology
  • World
  • Demand

Cancer Mortality for Selected Sites in ## Countries (1950-1957).

  • Dermatology
  • Anacor Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • GlobalData's company
  • Regeneron Pharmaceuticals, Inc.

The dermatology diagnostic devices market in Germany is primarily driven by the increasing demand from aging population and increasing skin cancer and disorders.

  • Dermatology
  • Diagnostic Imaging
  • Microscope
  • Europe
  • Forecast

The active ingredient of a-fragment has a specific suppressing effect on invasion and metastasis of cancer cells such as gallbladder cancer, lung cancer and other, which are highly metastatic and result in a high mortality.

  • Dermatology
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation

The company' s product focuses on epigenetics, cancer stem cells and cancer immunotherapy.

  • Dermatology
  • Pharmaceutical
  • Japan
  • United States
  • Maruho Co., Ltd.
  • SECONDARY OUTCOME MEASURES ARE PHARMACOKINETICS AND PRELIMINARY EFFICACY. ESTIMATED PRIMARY COMPLETION DATE IS OCTOBER 2012.

AMINAH JATOI, AT THE MAYO CLINIC CANCER CENTER.

  • Anti-Infective
  • Dermatology
  • Pharmaceutical
  • United States
  • Product Initiative

cancer indications with a high unmet medical need.

  • Dermatology
  • Endocrine Disease
  • World
  • Deals & Alliance
  • AstraZeneca PLC
  • Clinical Trial profile. 231 Trial Title
  • Clinical Trial profile. 169 Trial Title

The study met its primary regulatory endpoint, demonstrating that Ameluz in combination with daylight PDT was noninferior (p##. ##) to standard of care MAL Metvix) for the treatment of mild to moderate actinic keratosis (AK), a superficial early skin cancer.

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 3 Trial Title
  • Clinical Trial profile. 40 Trial Title
  • Dermatological Condition
  • Dermatology
  • Pathology
  • World
  • Product Initiative

The company' s pipeline products include PV-## for recurrent melanoma, PV-## for metastatic liver cancer and PV-## for recurrent breast cancer.

  • Dermatology
  • Hospital
  • United States
  • Product Initiative
  • Cellceutix Corporation
  • Clinical Trial profile. 790 Trial Title
  • Trial Identifier Secondary ID(s)

Cancer Patients Receiving Postmastectomy Radiation: A Randomized Trial, Double Blind Trial Mometasone Furoate ##. ##% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation GDCT## NCT##, ##-##; CDR##; MSKCC-##-##

  • Dermatological Condition
  • Dermatological Treatment
  • Dermatology
  • World
  • Novartis AG

Cancer Subjects A Clinical Study of Prophylactic Minocycline for the Skin Toxicities Induced by Erlotinib Plus Gemcitabine in Advanced Pancreatic Cancer Subjects GDCT## GDC##, Dermatology Skin And Soft Tissue Infections, Skin Rash, Xerosis (Dry Skin) Completed Phase II I

  • Dermatological Condition
  • Dermatology
  • Pathology
  • World
  • Product Initiative

GlaxoSmithKline; Merck & Co; Lexicon Pharmaceuticals, and other cancer research institutions such as Cancer Research Technology, and Institute of Cancer Research for drug discovery.

  • Dermatology
  • Europe
  • Spain
  • Company Financials
  • Almirall, S.A.

THE COMPANY DEVELOPS DRUGS FOR DIABETES AND CANCER.

  • Ambulatory Care
  • Dermatology
  • Canada
  • United States
  • Valeant Pharmaceuticals International, Inc.
  • Clinical Trial profile. 252 Trial Title

Lee Moffitt Cancer Center & Research Institute Inc ## Jul 2011 ## Feb 2012 ## ## ## ## Phase I Clinical Trial of PF-## Phase I Clinical Trial of PF-## GDCT## GDC##, Dermatology Alopecia Terminated Phase I Interventional PF-## Pfizer Inc Clinical Trial profile. ##

  • Dermatology
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Allergan plc

Lee Moffitt Cancer Center & Research Institute Inc ## Jul 2011 ## Feb 2012 Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Phase I Clinical Trial of

  • Dermatology
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Allergan plc